Osteo Bi-Flex passes advertising scrutiny
NEW YORK — The National Advertising Division of the Council of Better Business Bureaus earlier this month determined that Rexall Sundown has supported claims regarding the company’s Osteo Bi-Flex glucosamine HCL and vitamin D3 dietary supplement.
As a part of its ongoing monitoring program and in conjunction with the NAD’s initiative with the Council for Responsible Nutrition, designed to expand the NAD’s review of advertising claims for dietary supplements, the NAD — the advertising industry’s self-regulatory forum — reviewed claims that included:
“Joint support formula designed to show improvement in joint comfort within seven days”;
“5-LOXIN Advanced, a patent-pending special natural extract of Boswellia serrata that shows improvement in joint comfort within seven days”;
“Promotes neuromuscular function”;
“Supports overall immune system health”; and
“No. 1 doctor- and pharmacist-recommended brand.”
In support of its advertising claims, the advertiser identified the proven joint health benefits of glucosamine and vitamin D3, as well as research on the Boswellia serrata extract in this product.
Rexall Sundown acknowledged that the current research on glucosamine alone could not support a “seven-day efficacy" claim, but maintained that its seven-day claim was supported by the highly absorbable Boswellia extract ingredient aflapin, which is marketed as 5-Loxin Advanced.
Following its review of the evidence in the record, including research on aflapin, the NAD determined that the advertiser could support claims that referenced an improvement in joint comfort in or within seven days. The NAD further determined that the body of evidence on vitamin D provides a reasonable basis for the claims that it “promotes neuromuscular function” and “supports overall immune system health.”
Finally, the NAD found that, based on data contained in the current National Disease and Therapeutic Index, the advertiser could support the claim that Osteo Bi-Flex is the “No. 1 doctor- and pharmacist-recommended brand.”
Luden’s new drops tout vitamin C
IRVINGTON, N.Y. — Prestige Brands recently extended its Luden’s throat drop brand with Luden’s orange supplement drops, a vitamin-enriched product with 100% of the recommended daily value of vitamin C.
“We’re confident that anyone with minor throat discomfort is going to love Luden’s orange supplement drops,” Luden’s VP marketing Albert Hwang said. “Luden’s is all about soothing throat irritations with great-tasting throat drops. Now we also have Luden’s orange supplement drops, with real orange juice and vitamin C.”
Suggested retail price for the new Luden’s orange supplement drops is $1.79.
Perrigo’s acquisition of Paddock Labs put on hold
ALLEGAN, Mich. — Perrigo on Wednesday announced that its closing date to complete the acquisition of Paddock Labs — a generic pharmaceutical and specialty over-the-counter products manufacturer — has been delayed by an extended Federal Trade Commission review.
"We are looking forward to concluding the transaction as soon as possible,” Perrigo chairman and CEO Joseph Papa said. “We have recently received a few additional questions from the Federal Trade Commission staff, and the parties are working collaboratively with the staff to answer these questions so that the FTC may conclude its review,” he said.
The acquisition is an important step toward expanding Perrigo’s specialty portfolio of generic pharmaceutical products, Papa said.